408 related articles for article (PubMed ID: 25660553)
1. Microbiota modulation of myeloid cells in cancer therapy.
Goldszmid RS; Dzutsev A; Viaud S; Zitvogel L; Restifo NP; Trinchieri G
Cancer Immunol Res; 2015 Feb; 3(2):103-9. PubMed ID: 25660553
[TBL] [Abstract][Full Text] [Related]
2. Microbiota-myeloid cell crosstalk beyond the gut.
Gorjifard S; Goldszmid RS
J Leukoc Biol; 2016 Nov; 100(5):865-879. PubMed ID: 27605211
[TBL] [Abstract][Full Text] [Related]
3. The role of the microbiota in inflammation, carcinogenesis, and cancer therapy.
Dzutsev A; Goldszmid RS; Viaud S; Zitvogel L; Trinchieri G
Eur J Immunol; 2015 Jan; 45(1):17-31. PubMed ID: 25328099
[TBL] [Abstract][Full Text] [Related]
4. The influence of the commensal microbiota on distal tumor-promoting inflammation.
Buchta Rosean CM; Rutkowski MR
Semin Immunol; 2017 Aug; 32():62-73. PubMed ID: 28687194
[TBL] [Abstract][Full Text] [Related]
5. Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses.
Hossain F; Majumder S; Ucar DA; Rodriguez PC; Golde TE; Minter LM; Osborne BA; Miele L
Front Immunol; 2018; 9():1288. PubMed ID: 29915603
[TBL] [Abstract][Full Text] [Related]
6. Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.
Parker KH; Beury DW; Ostrand-Rosenberg S
Adv Cancer Res; 2015; 128():95-139. PubMed ID: 26216631
[TBL] [Abstract][Full Text] [Related]
7. Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected.
Marvel D; Gabrilovich DI
J Clin Invest; 2015 Sep; 125(9):3356-64. PubMed ID: 26168215
[TBL] [Abstract][Full Text] [Related]
8. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment.
Iida N; Dzutsev A; Stewart CA; Smith L; Bouladoux N; Weingarten RA; Molina DA; Salcedo R; Back T; Cramer S; Dai RM; Kiu H; Cardone M; Naik S; Patri AK; Wang E; Marincola FM; Frank KM; Belkaid Y; Trinchieri G; Goldszmid RS
Science; 2013 Nov; 342(6161):967-70. PubMed ID: 24264989
[TBL] [Abstract][Full Text] [Related]
9. The lung microbiota: role in maintaining pulmonary immune homeostasis and its implications in cancer development and therapy.
Sommariva M; Le Noci V; Bianchi F; Camelliti S; Balsari A; Tagliabue E; Sfondrini L
Cell Mol Life Sci; 2020 Jul; 77(14):2739-2749. PubMed ID: 31974656
[TBL] [Abstract][Full Text] [Related]
10. Innate immune mediators in cancer: between defense and resistance.
Berraondo P; Minute L; Ajona D; Corrales L; Melero I; Pio R
Immunol Rev; 2016 Nov; 274(1):290-306. PubMed ID: 27782320
[TBL] [Abstract][Full Text] [Related]
11. Myeloid cells as orchestrators of the tumor microenvironment: novel targets for nanoparticular cancer therapy.
Tuettenberg A; Steinbrink K; Schuppan D
Nanomedicine (Lond); 2016 Oct; 11(20):2735-2751. PubMed ID: 27658725
[TBL] [Abstract][Full Text] [Related]
12. Harnessing immune checkpoints in myeloid lineage cells for cancer immunotherapy.
Park SY; Kim IS
Cancer Lett; 2019 Jun; 452():51-58. PubMed ID: 30910590
[TBL] [Abstract][Full Text] [Related]
13. Targeting cancer-related inflammation in the era of immunotherapy.
Nakamura K; Smyth MJ
Immunol Cell Biol; 2017 Apr; 95(4):325-332. PubMed ID: 27999432
[TBL] [Abstract][Full Text] [Related]
14. Innate Immune Defense Mechanisms by Myeloid Cells That Hamper Cancer Immunotherapy.
Lebegge E; Arnouk SM; Bardet PMR; Kiss M; Raes G; Van Ginderachter JA
Front Immunol; 2020; 11():1395. PubMed ID: 32733461
[TBL] [Abstract][Full Text] [Related]
15. Immature myeloid cells in the tumor microenvironment: Implications for immunotherapy.
Kamran N; Chandran M; Lowenstein PR; Castro MG
Clin Immunol; 2018 Apr; 189():34-42. PubMed ID: 27777083
[TBL] [Abstract][Full Text] [Related]
16. Roles of microbiota in response to cancer immunotherapy.
Inamura K
Semin Cancer Biol; 2020 Oct; 65():164-175. PubMed ID: 31911189
[TBL] [Abstract][Full Text] [Related]
17. Myeloid-Derived Suppressor Cells and Proinflammatory Cytokines as Targets for Cancer Therapy.
Atretkhany KN; Drutskaya MS
Biochemistry (Mosc); 2016 Nov; 81(11):1274-1283. PubMed ID: 27914453
[TBL] [Abstract][Full Text] [Related]
18. β-glucan restores tumor-educated dendritic cell maturation to enhance antitumor immune responses.
Ning Y; Xu D; Zhang X; Bai Y; Ding J; Feng T; Wang S; Xu N; Qian K; Wang Y; Qi C
Int J Cancer; 2016 Jun; 138(11):2713-23. PubMed ID: 26773960
[TBL] [Abstract][Full Text] [Related]
19. Microbiome, inflammation, and cancer.
Francescone R; Hou V; Grivennikov SI
Cancer J; 2014; 20(3):181-9. PubMed ID: 24855005
[TBL] [Abstract][Full Text] [Related]
20. MDSCs in cancer: Conceiving new prognostic and therapeutic targets.
De Sanctis F; Solito S; Ugel S; Molon B; Bronte V; Marigo I
Biochim Biophys Acta; 2016 Jan; 1865(1):35-48. PubMed ID: 26255541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
